Brief: Oncolytics Biotech Posts Q4 Loss Per Share Of C$0.14
03/03/2022 21:14
March 3 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS
* Q4 LOSS PER SHARE C$0.14
Source text for Eikon: ID:nCNWhM9ywa
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer